Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes

Hematology Journal

Volumn 2, Issue 1, 2001, Pages 33-37

  Meletis, J ^a   Terpos, E ^a   Samarkos, M ^a   Meletis, C ^a   Apostolidou, E ^a   Komninaka, V ^a   Korovesis, K ^a   Mavrogianni, D ^a   Boutsis, D ^a   Variami, E ^a   Viniou, N ^a   Konstantopoulos, K ^a   Loukopoulos, D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

CD55; CD59; Hodgkin's disease; Lymphoproliferative syndromes; Non Hodgkin's lymphoma; Paroxysmal nocturnal hemoglobinuria

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; GLYPICAN; SUCROSE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; B LYMPHOCYTE; BLOOD DONOR; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOPENIA; DISEASE ASSOCIATION; ERYTHROCYTE; FEMALE; HAIRY CELL LEUKEMIA; HEMATOLOGIC DISEASE; HODGKIN DISEASE; HUMAN; HUMAN CELL; INTRAVASCULAR HEMOLYSIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD55; ANTIGENS, CD59; CASE-CONTROL STUDIES; ERYTHROCYTES; FEMALE; HEMATOLOGIC NEOPLASMS; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED;

EID: 0035065574     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200077     Document Type: Article

References (22)

1. The molecular basis of paroxysmal nocturnal hemoglobinuria
2. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria
3. The molecular basis of paroxysmal nocturnal hemoglobinuria
4. Phosphatydilinositol-linked proteins and paroxysmal nocturnal hemoglobinuria
5. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: Search for a pathogenetic link
6. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes
7. The PNH abnormality in myeloproliferative disorders: Association of PNH and acute erythremic myelosis in two children
8. Detection of 'PNH Red Cell' populations in hematological disorders using the sephacryl gel test micro typing system
9. Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma
10. Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (CMP) and CD55 (DAF) in hematological malignancies
11. Deficiency of complement decay-accelerating factor (DAF, CD55) in non-Hodgkin's lymphoma
12. Paroxysmal nocturnal haemoglobinuria: Clinical manifestations, haematology and nature of disease
13. Flow cytometric measurement of Glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria
14. Paroxysmal nocturnal hemoglobinuria. Diagnosis aided by a monoclonal antibody directed against the decay accelerating factor glycoprotein
15. - erythrocytes in microtyping cards
16. Diagnostic rapide des hemoglobinuries nocturnes paroxystiques par agglutination en gel
17. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting
18. The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment
19. Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria
20. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals
21. Paroxysmal nocturnal hemoglobinuria
22. Paroxysmal nocturnal hemoglobinuria: Learning about PNH cells from patients and mice